Swastika Maity
Manipala, KA 576104, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Quality by Design-Based RP-HPLC Method for Simultaneous Estimation of 4-Hydroxytamoxifen and Thymoquinone in Liposomal Formulation.
Journal: Biomedical chromatography : BMC
Published: December 16, 2025
Multi-target Agents in Complex Diseases: From Design Principles to Therapeutic Applications.
Journal: Current drug targets
Published: December 02, 2025
Focal adhesion kinase (FAK): emerging target for drug-resistant malignant tumors.
Journal: Molecular biology reports
Published: December 03, 2024
Network pharmacology and in silico approaches to uncover multitargeted mechanism of action of Zingiber zerumbet rhizomes for the treatment of idiopathic pulmonary fibrosis.
Journal: F1000Research
Published: June 10, 2024
Emvolio - A battery operated portable refrigerator preserves biochemical and haematological integrity of biological samples in preclinical studies.
Journal: F1000Research
Published: September 19, 2023
Enhancing temozolomide antiglioma response by inhibiting O6-methylguanine-DNA methyltransferase with selected phytochemicals: in silico and in vitro approach.
Journal: 3 Biotech
Published: February 01, 2023
Computational drug repurposing of Akt-1 allosteric inhibitors for non-small cell lung cancer.
Journal: Scientific reports
Published: December 02, 2022
Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis.
Journal: Inflammopharmacology
Published: November 10, 2022
In silico screening of neurokinin receptor antagonists as a therapeutic strategy for neuroinflammation in Alzheimer's disease.
Journal: Molecular diversity
Published: April 13, 2021
SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study.
SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study.
Journal: European journal of pharmacology
Published: November 25, 2020
Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19.
Journal: F1000Research
Published: September 15, 2020
Last Updated: 09/26/2026